Breakthrough antibody therapy targets Alzheimer’s risk gene, offers hope for effective treatment Post author: Post published: October 6, 2023 Post category:uncategorized Researchers introduced and characterized a novel platform based on monoclonal antibodies (mAbs). You Might Also Like OCT imaging sheds light on embryo transport mechanism in the oviduct July 15, 2025 Ultrasound technology breaks blood-brain barrier for glioblastoma treatment June 6, 2024 CIRM awards $7.4 million to advance stem cell-based gene therapy for Friedreich’s ataxia January 8, 2026
CIRM awards $7.4 million to advance stem cell-based gene therapy for Friedreich’s ataxia January 8, 2026